Latest & greatest articles for acute pain

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on acute pain or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on acute pain and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for acute pain

162. BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain

BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain | Guidance and guidelines | NICE BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain Medical technologies guidance [MTG4] Published date: June 2011 Guidance In November 2016, NICE reviewed this guidance and recommended that the guidance should be withdrawn. The guidance

National Institute for Health and Clinical Excellence - Medical technologies2011

163. The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisis in Sickle Cell Disease: A Systematic Review

The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisis in Sickle Cell Disease: A Systematic Review "The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisi" by Kristina Huffaker < > > > > > Title Author Date of Award Spring 4-2011 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Torry Cobb, DHSc, MPH, PA-C Second Advisor Annjanette Sommers MS, PAC Rights . Abstract Background: Acute vaso-occlusive crisis (...) outcome of decreased pain was graded as a moderate. Other outcomes of length of hospital stay and amount of pain medication used were also graded as moderate, however the outcomes of methemoglobin levels and harm were graded as high quality outcomes. Conclusion: It is difficult to clearly state that inhaled nitric oxide does or does not decrease pain in acute vaso-occlusive crisis in patients with Sickle Cell disease. No adverse side effects have been seen, and some patients have reported decreased

Pacific University EBM Capstone Project2011

164. Acute Low Back Pain

Acute Low Back Pain 1 Quality Department Guidelines for Clinical Care Ambulatory Low Back Pain Guideline Team Team leader Anthony E. Chiodo, MD Physical Medicine & Rehabilitation Team members David J. Alvarez, DO Family Medicine Gregory P. Graziano, MD Orthopedic Surgery Andrew J. Haig, MD Physical Medicine & Rehabilitation R. Van Harrison, PhD Medical Education Paul Park, MD Neurosurgery Connie J. Standiford, MD General Internal Medicine Consultant Ronald A. Wasserman, MD Anesthesiology, Back (...) and Pain Center Initial Release November, 1997 Interim/Minor Revision December, 2011 Most Recent Major Update January, 2010 Ambulatory Clinical Guidelines Oversight William E. Chavey, MD R. Van Harrison, PhD Connie J. Standiford, MD Literature Search Service Taubman Health Sciences Library For more information 734-936-9771 © Regents of the University of Michigan Acute Low Back Pain Patient population: Adults (>18 years) with pain 3 weeks: If no improvement obtain MRI [IIB*]. If not diagnostic, obtain

University of Michigan Health System2011

165. Diflunisal is an effective analgesic for acute postoperative pain.

Diflunisal is an effective analgesic for acute postoperative pain. Diflunisal is an effective analgesic for acute postoperative pain. ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take advantage of endorsed, discounted business products Purchase ADA products (...) is an effective analgesic for acute postoperative pain. Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of diflunisal (500 to 1000 mg) effectively relieves pain for 12 hours in adults with acute moderate-to-severe pain symptoms. Critical Summary Assessment This high-quality review of nine random controlled trials (RCTs) found that diflunisal is an effective analgesic that causes mild adverse effects at higher doses (1000 mg). Evidence Quality Rating

ADA Center for Evidence-Based Dentistry2010

166. Diflunisal is an effective analgesic for acute postoperative pain.

Diflunisal is an effective analgesic for acute postoperative pain. Diflunisal is an effective analgesic for acute postoperative pain. ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Purchase ADA products (...) is an effective analgesic for acute postoperative pain. Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of diflunisal (500 to 1000 mg) effectively relieves pain for 12 hours in adults with acute moderate-to-severe pain symptoms. Critical Summary Assessment This high-quality review of nine random controlled trials (RCTs) found that diflunisal is an effective analgesic that causes mild adverse effects at higher doses (1000 mg). Evidence Quality Rating

ADA Center for Evidence-Based Dentistry2010

167. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial

Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial 20382445 2010 11 01 2010 11 12 2013 11 21 1097-6760 56 5 2010 Nov Annals of emergency medicine Ann Emerg Med Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial. 509-16 10.1016/j.annemergmed.2010.03.020 We determine the best intravenous (...) opioid titration protocol by comparing morphine and sufentanil for adult patients with severe traumatic acute pain in an out-of-hospital setting, with a physician providing care. In this double-blind randomized clinical trial, patients were eligible for inclusion if aged 18 years or older, with acute severe pain (defined as a numeric rating scale score ≥ 6/10) caused by trauma. They were assigned to receive either intravenous 0.15 μg/kg sufentanil, followed by 0.075 μg/kg every 3 minutes

EvidenceUpdates2010

168. The costs and benefits of extending the role of the acute pain service on clinical outcomes after major elective surgery

The costs and benefits of extending the role of the acute pain service on clinical outcomes after major elective surgery 20705784 2010 09 27 2010 10 11 2014 11 20 1526-7598 111 4 2010 Oct Anesthesia and analgesia Anesth. Analg. The costs and benefits of extending the role of the acute pain service on clinical outcomes after major elective surgery. 1042-50 10.1213/ANE.0b013e3181ed1317 Acute pain services have received widespread acceptance and formal support from institutions and organizations (...) , but available evidence on their costs and benefits is scarce. Although there is good agreement on the provision of acute pain services after many major surgical procedures, there are other procedures for which the benefits are unclear. Data are required to justify any expansion of acute pain services. In this randomized, controlled clinical trial we compared the costs and effects of acute pain service care on clinical outcomes with conventional pain management on the ward. Patients included in the trial

EvidenceUpdates2010

169. Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures

Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take (...) website Evidence Education About * Associated Topics Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of codeine 60 mg provides poor analgesia in adults having acute moderate to severe pain. Critical Summary Assessment This high-quality of good evidence from 35 double-blind, randomized controlled trials (2,411 participants) finds

ADA Center for Evidence-Based Dentistry2010

170. Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures

Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make (...) health website Evidence Education About * Associated Topics Good evidence finds codeine is a poor analgesic for acute moderate to severe pain from dental procedures Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of codeine 60 mg provides poor analgesia in adults having acute moderate to severe pain. Critical Summary Assessment This high-quality of good evidence from 35 double-blind, randomized controlled trials (2,411 participants) finds

ADA Center for Evidence-Based Dentistry2010

171. Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features

Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features 20691302 2010 08 09 2010 09 21 2016 11 25 1879-1913 106 4 2010 Aug 15 The American journal of cardiology Am. J. Cardiol. Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features. 463-9 10.1016/j.amjcard.2010.03.058 The accuracy of 64-slice computed tomographic coronary angiography (CTA) and its ability (...) to direct revascularization in patients with acute chest pain syndrome (ACPS) was investigated. A total of 107 patients with ACPS presenting to the emergency department and referred to cardiology were prospectively enrolled and underwent CTA. From the clinical features, the patients were categorized as having high-risk acute coronary syndrome features or no high-risk features. At the treating physician's discretion, the patients underwent risk stratification with either invasive coronary angiography

EvidenceUpdates2010

172. Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain

Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable (...) children's oral health website Evidence Education About * Associated Topics Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion Good evidence suggests that single doses of both ketoprofen at 25 and 50 mg and of dexketoprofen at 10 to 25 mg effectively reduce acute moderate-to-severe postoperative pain in adults with minimal adverse effects. Critical

ADA Center for Evidence-Based Dentistry2010

173. Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain

Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make (...) health website Evidence Education About * Associated Topics Good evidence for ketoprofen and dexketoprofen as effective and safe analgesics for acute postoperative pain Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion Good evidence suggests that single doses of both ketoprofen at 25 and 50 mg and of dexketoprofen at 10 to 25 mg effectively reduce acute moderate-to-severe postoperative pain in adults with minimal adverse effects. Critical Summary

ADA Center for Evidence-Based Dentistry2010

174. Limited evidence for single-dose etodolac for acute postoperative pain

Limited evidence for single-dose etodolac for acute postoperative pain Limited evidence for single-dose etodolac for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take advantage of endorsed, discounted business products Purchase ADA (...) evidence for single-dose etodolac for acute postoperative pain Arthur Jeske DMD, PhD . Overview Systematic Review Conclusion Adequate-quality but limited evidence suggests single-dose etodolac effectively reduces acute moderate to severe postoperative pain in adults with minimal adverse effects. Critical Summary Assessment A high-quality of 9 double-blind randomized controlled trials (RCTs) suggests that single doses of etodolac 25 mg to 1,200 mg provide at least 50% relief of moderate to severe

ADA Center for Evidence-Based Dentistry2010

175. Limited evidence for single-dose etodolac for acute postoperative pain

Limited evidence for single-dose etodolac for acute postoperative pain Limited evidence for single-dose etodolac for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Purchase ADA (...) evidence for single-dose etodolac for acute postoperative pain Arthur Jeske DMD, PhD . Overview Systematic Review Conclusion Adequate-quality but limited evidence suggests single-dose etodolac effectively reduces acute moderate to severe postoperative pain in adults with minimal adverse effects. Critical Summary Assessment A high-quality of 9 double-blind randomized controlled trials (RCTs) suggests that single doses of etodolac 25 mg to 1,200 mg provide at least 50% relief of moderate to severe

ADA Center for Evidence-Based Dentistry2010

176. WITHDRAWN: Bed rest for acute low-back pain and sciatica.

WITHDRAWN: Bed rest for acute low-back pain and sciatica. BACKGROUND: Low-back pain (LBP) is a common reason for consulting a general practitioner, and advice on daily activities is an important part of the primary care management of low-back pain. OBJECTIVES: To assess the effects of advice to rest in bed for patients with acute LBP or sciatica. SEARCH STRATEGY: We searched the Cochrane Back Group Specialized Registry, CENTRAL, MEDLINE, EMBASE, Sport, and SCISEARCH to March 2003, reference (...) validity of included trials and extracted data. Investigators were contacted to obtain missing information. MAIN RESULTS: Eleven trials (1963 patients) were included in this updated version. There is high quality evidence that people with acute LBP who are advised to rest in bed have a little more pain [Standardised Mean Difference (SMD) 0.22 (95% Confidence Interval (CI): 0.02, 0.41)] and a little less functional recovery [SMD 0.29 (95% CI: 0.05, 0.45)] than those advised to stay active. For patients

Cochrane2010

177. Limited evidence for single-dose flurbiprofen for acute postoperative pain

Limited evidence for single-dose flurbiprofen for acute postoperative pain Limited evidence for single-dose flurbiprofen for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take advantage of endorsed, discounted business products (...) Topics Limited evidence for single-dose flurbiprofen for acute postoperative pain Arthur Jeske DMD, PhD . Overview Systematic Review Conclusion Flurbiprofen 50 mg or 100 mg is an effective analgesic in postoperative pain. The NNT for at least 50% pain relief is 2.5 and similar to that of other common NSAIDs, with a 6-hour duration. Critical Summary Assessment This of 11 trials of acceptable quality, but had a limited number of participants (1,646 total, 362 placebo). The review suggests that single

ADA Center for Evidence-Based Dentistry2010

178. Limited evidence for single-dose flurbiprofen for acute postoperative pain

Limited evidence for single-dose flurbiprofen for acute postoperative pain Limited evidence for single-dose flurbiprofen for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization (...) Topics Limited evidence for single-dose flurbiprofen for acute postoperative pain Arthur Jeske DMD, PhD . Overview Systematic Review Conclusion Flurbiprofen 50 mg or 100 mg is an effective analgesic in postoperative pain. The NNT for at least 50% pain relief is 2.5 and similar to that of other common NSAIDs, with a 6-hour duration. Critical Summary Assessment This of 11 trials of acceptable quality, but had a limited number of participants (1,646 total, 362 placebo). The review suggests that single

ADA Center for Evidence-Based Dentistry2010

179. Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults.

Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take (...) website Evidence Education About * Associated Topics Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of etoricoxib (120 mg) provides good relief of post-surgical moderate to severe postoperative pain in two-thirds of adults with mild adverse effects similar to those of placebo. Critical Summary Assessment High quality evidence supports

ADA Center for Evidence-Based Dentistry2010

180. Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults.

Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make (...) health website Evidence Education About * Associated Topics Substantial evidence finds etoricoxib is an effective analgesic for acute postoperative pain in adults. Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion A single dose of etoricoxib (120 mg) provides good relief of post-surgical moderate to severe postoperative pain in two-thirds of adults with mild adverse effects similar to those of placebo. Critical Summary Assessment High quality evidence

ADA Center for Evidence-Based Dentistry2010